Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney diseasePediatric Nephrology.  33:325-333. 2018
2017 Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studiesPediatric Nephrology.  32:743-751. 2017
2016 Smaller circuits for smaller patients: improving renal support therapy with Aquadexâ„¢Pediatric Nephrology.  31:853-860. 2016
2015 Progression of pediatric CKD of nonglomerular origin in the CKiD cohortClinical Journal of the American Society of Nephrology.  10:571-577. 2015
2014 Expanding the phenotype of proteinuria in Dent disease. A case seriesPediatric Nephrology.  29:2051-2054. 2014
2014 Uric acid and the kidneyPediatric Nephrology.  29:999-1008. 2014
2012 An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjectsPediatric Nephrology.  27:1953-1959. 2012
2008 IgA Nephropathy in children and adults: Comparison of histologic features and clinical outcomesNephrology Dialysis Transplantation.  23:2537-2545. 2008
2006 Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gainPediatric Nephrology.  21:1179-1184. 2006
2003 Stages of status epilepticus in the developing brainEpilepsy Research.  55:9-19. 2003

Investigator On

  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Kidney Undergraduate Research Experience (KURE)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • NGAL Usage In Determining AKI Risk in Critically Ill Children (GUIDANCE)  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by RETROPHIN, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by OCTAPHARMA - NEW
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by WATERMARK RESEARCH PARTNERS INC
  • Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • The Genetic Contribution to Drug Induced Renal lnjury:The Drug Induced Renal Injury Consortium (DIRECT)  awarded by INTERNATIONAL SAE CONSORTIOUM, LTD
  • Viral Triggers of Alioimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University
  • Education And Training

  • American University of Beirut Medical Center, Internship
  • American University of Beirut Medical Center, Residency
  • Cook County Hospital, Residency
  • Children's Memorial Hospital, Postdoctoral Fellowship
  • University of Texas Southwestern Medical Center, Postdoctoral Fellowship
  • Doctor of Medicine, 2008
  • Full Name

  • Sahar Fathallah-Shaykh